Antiplaque Comments
This article was originally published in The Rose Sheet
Executive Summary
New date for comments on advance notice of proposed rulemaking for OTC Antigingivitis/ Antiplaque Drug Products is Nov. 25, FDA announces. Reply comment period also has been extended to Feb. 23, 2004, agency says in Federal Register notice slated to appear Aug. 25. CHPA, CTFA jointly requested the extension in a July 15 petition (1"The Rose Sheet" July 28, 2003, In Brief). Groups wanted extra time to review data on ingredients the agency has proposed classifying as Category III (insufficient data) rather than Category I (safe and effective)...